Stock to Watch: CEL-SCI Up 11.2% (CVM)
CEL-SCI (AMEX:CVM) is one of today's best performing penny stocks, up 11.2% to $0.27 on 1.8x average daily volume. CEL-SCI has traded 2.4 million shares thus far today, vs. average volume of 1.3 million shares per day. The stock has outperformed the Dow (11.2% to the Dow's -0.2%) and outperformed the S&P 500 (11.2% to the S&P's -0.1%) during today's trading.
CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.
There is potential upside of 173.6% for shares of CEL-SCI based on a current price of $0.27 and an average consensus analyst price target of $0.73. CEL-SCI shares should encounter resistance at the 200-day moving average (MA) of $0.27 and support at the 50-day MA of $0.22.
Over the past year, CEL-SCI has traded in a range of $0.16 to $0.47 and is now at $0.27, 66% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 1.5% while the 50-day MA has declined 2.6%.
SmarTrend recommended that its subscribers protect gains by selling shares of CEL-SCI on May 21st, 2012 by issuing a Downtrend alert when the shares were trading at $0.40. Since that call, shares of CEL-SCI have fallen 39.6%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Keywords: penny stocks amex:cvm cel-sci